Biodesign for Digital Health
Health care is facing significant cross-industry challenges and opportunities created by a number of factors including: the increasing need for improved access to affordable, high-quality care; growing demand from consumers for greater control of their health and health data; the shift in focus from “sick care” to prevention and health optimization; aging demographics and the increased burden of chronic conditions; and new emphasis on real-world, measurable health outcomes for individuals and populations. Moreover, the delivery of health information and services is no longer tied to traditional “brick and mortar” hospitals and clinics: it has increasingly become "Digital," enabled by apps, sensors, wearables; simultaneously, it has been augmented and often revolutionized by emerging digital and information technologies, as well as by the data that these technologies generate. This multifactorial transformation presents opportunities for innovation across the entire cycle of care, from wellness, to acute and chronic diseases, to care at the end of life
But how does one approach innovation in digital health to address these healthcare challenges while ensuring the greatest chance of success?
At Stanford Biodesign, we believe that innovation is a process that can be learned, practiced, and perfected; and, it starts with a need. In Biodesign for Digital Health, students will learn about digital health and the Biodesign needs-driven innovation process from over 50 industry experts. Over the course of ten weeks, these speakers join the teaching team in a dynamic classroom environment that includes lectures, panel discussions, and breakout sessions. These experts represent startups, corporations, venture capital firms, accelerators, research labs, health organizations, and more.
Student teams will take actual digital and mobile health challenges and learn how to apply Biodesign innovation principles to research and evaluate needs, ideate solutions, and objectively assess them against key criteria for satisfying the needs. Teams take a hands-on approach with the support of need coaches and mentors. On the final day of class, teams present to a panel of digital health experts and compete for project extension funding. Learn more about Biodesign NEXT and read about the winning teams from past years.
Enrollment in the course is limited, and by application only. Friday sessions will be used for work time on team projects and for two scheduled workshops (no classes). Additional information is provided in the course syllabus, or check out the course flier.
|Biodesign for Digital Health|
Digital Course Leaders
- Oliver Aalami Lead Director, Biodesign for Digital Health
- Marta Gaia Zanchi Founding Director, Biodesign for Digital Health
- Paul Yock Founder, Director
- Shiqin Xu Course Manager
Advisory Board Members
- Yogen Dalal Partner Emeritus, Mayfield. Chairman and Co-Founder, Glooko
- Mark Zdeblick Co-Founder, Chief Technology Officer, Proteus Digital Health
- Cheryl Cheng Partner, BlueRun Ventures, Co-Founder, BrandGarage
- Michael McConnell CARDIOVASCULAR MEDICINE
- Asha Nayak Global Medical Director, Intel Corporation
- Paul Wang Professor of Medicine and of Bioengineering, Stanford University